Physician Assistant · Houston, TX
NPI
1659449536
Since 2006
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
236 services
Medicare patients, 2024
109
Average age 72
Drug cost, 2024
$8.6M
899 prescriptions
Company payments, 2025
$1,375
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zita D Lim was code 99214 (office e&m - established), 115 times for 75 patients. In total Zita D Lim billed 236 services in 9 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-09-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 115 | 75 | $62.54 | $7,192 |
| 99213 Office E&M - Established | Facility | 69 | 47 | $40.64 | $2,804 |
| 99215 Office E&M - Established | Facility | 17 | 14 | $97.65 | $1,660 |
By year: 2022 $13K for 225 services; 2023 $13K for 235 services; 2024 $13K for 236 services.
Medicare prescription drug claims, 2024
In 2024, the drug Zita D Lim prescribed most often to Medicare patients was Cabometyx (Cabozantinib S-Malate), with 107 prescriptions and refills. In total Zita D Lim wrote 899 Medicare prescriptions that cost $8.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cabometyx Cabozantinib S-Malate | 107 | 107 | 19 | $2.6M |
| Eliquis Apixaban | 83 | 95 | 17 | $55K |
| Levothyroxine Sodium Generic | 74 | 146 | 29 | $515 |
| Lenvima Lenvatinib Mesylate | 68 | 68 | 14 | $1.7M |
| Welireg Belzutifan | 63 | 63 | 16 | $1.8M |
| Inlyta Axitinib | 57 | 57 | Under 11 | $1.2M |
| Nifedipine Er Nifedipine | 37 | 61 | 13 | $1,061 |
| Fotivda Tivozanib Hcl | 35 | 35 | Under 11 | $1.0M |
| Ondansetron Hcl Generic | 33 | 35 | 14 | $426 |
| Everolimus Generic | 28 | 32 | Under 11 | $84K |
| Carvedilol Generic | 22 | 46 | Under 11 | $185 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 16 | 17 | 11 | $318 |
| Colestipol Hcl Generic | 15 | 21 | Under 11 | $763 |
| Metoprolol Succinate Generic | 12 | 14 | Under 11 | $121 |
| Sunitinib Malate Generic | 12 | 12 | Under 11 | $45K |
Brand drugs: 498 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zita D Lim $1,375 ($1,375 in general payments such as food, travel and fees) from 8 companies. The largest payer was Exelixis Inc. with $863.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.